Adicon Holdings Limited (9860.HK) Stock Competitors & Peer Comparison

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 2359.HK has a market cap of 452.4B. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 2359.HK trades at HK$157.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 2359.HK's P/E ratio is 20.03. In terms of profitability, 9860.HK's ROE is N/A, compared to 2359.HK's ROE of +0.27%. Regarding short-term risk, 9860.HK is more volatile compared to 2359.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9860.HK.Check 2359.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 2268.HK has a market cap of 71.4B. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 2268.HK trades at HK$56.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 2268.HK's P/E ratio is 45.23. In terms of profitability, 9860.HK's ROE is N/A, compared to 2268.HK's ROE of +0.16%. Regarding short-term risk, 9860.HK is less volatile compared to 2268.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9860.HK.Check 2268.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 6127.HK has a market cap of 32.3B. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 6127.HK trades at HK$23.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 6127.HK's P/E ratio is 31.05. In terms of profitability, 9860.HK's ROE is N/A, compared to 6127.HK's ROE of +0.06%. Regarding short-term risk, 9860.HK is less volatile compared to 6127.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9860.HK.Check 6127.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 2251.HK has a market cap of 1.1B. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 2251.HK trades at HK$10.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 2251.HK's P/E ratio is -5.93. In terms of profitability, 9860.HK's ROE is N/A, compared to 2251.HK's ROE of -0.02%. Regarding short-term risk, 9860.HK is less volatile compared to 2251.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9860.HK.Check 2251.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 8037.HK has a market cap of 634.2M. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 8037.HK trades at HK$0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 8037.HK's P/E ratio is -3.18. In terms of profitability, 9860.HK's ROE is N/A, compared to 8037.HK's ROE of -0.31%. Regarding short-term risk, 9860.HK is more volatile compared to 8037.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9860.HK.Check 8037.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 2325.HK has a market cap of 380.5M. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 2325.HK trades at HK$0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 2325.HK's P/E ratio is -1.40. In terms of profitability, 9860.HK's ROE is N/A, compared to 2325.HK's ROE of +0.00%. Regarding short-term risk, 9860.HK is less volatile compared to 2325.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9860.HK.Check 2325.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 8247.HK has a market cap of 198M. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 8247.HK trades at HK$3.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 8247.HK's P/E ratio is -7.51. In terms of profitability, 9860.HK's ROE is N/A, compared to 8247.HK's ROE of N/A. Regarding short-term risk, 9860.HK is less volatile compared to 8247.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9860.HK.Check 8247.HK's competition here

9860.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 9860.HK stands at 2.9B. In comparison, 0928.HK has a market cap of 124M. Regarding current trading prices, 9860.HK is priced at HK$4.02, while 0928.HK trades at HK$0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

9860.HK currently has a P/E ratio of 91.72, whereas 0928.HK's P/E ratio is 8.65. In terms of profitability, 9860.HK's ROE is N/A, compared to 0928.HK's ROE of +0.01%. Regarding short-term risk, 9860.HK is less volatile compared to 0928.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9860.HK.Check 0928.HK's competition here